Parliamentary Search

Written question asked by Lord Goldsmith of Richmond Park (Conservative) on Tuesday, 18 July 2017, in the House of Commons. It was due for an answer on Thursday, 20 July 2017. It was answered by Philip Dunne (Conservative) on Monday, 24 July 2017 on behalf of the Department of Health.

Royal Brompton Hospital

Question

To ask the Secretary of State for Health, if he will ensure that patients of the specialised paediatric respiratory and paediatric cystic fibrosis services at the Royal Brompton Hospital will be fully consulted by the panel established to consider the potential effect of NHS England's congenital heart disease proposals on those services.

Answer

This is a matter for NHS England. No decision has been made to close the Congenital Heart Disease (CHD) service at the Royal Brompton and Harefield NHS Foundation Trust.

NHS England has advised that they have performed impact assessments for all centres which would be impacted by its CHD service change proposals if implemented. We have been informed by NHS England that these initial assessments acknowledged that there would be an impact on paediatric respiratory and cystic fibrosis services at the Royal Brompton, if NHS England’s proposals were implemented.

NHS England has advised that a panel including respiratory clinicians and representatives from respiratory and cystic fibrosis patient and public groups has been created to assess the potential impact of its CHD service change proposals on the Royal Brompton’s paediatric respiratory services. This panel has arranged to visit the Royal Brompton in August and has requested to meet patients as a part of this.

Secondary information

Type
Written question
Reference
5674
Session
2017-19
Subjects
Congenital abnormalities Heart diseases Paediatrics Royal Brompton Hospital
Link
View this Written question on www.parliament.uk